Rhinosinusitis and nasal polyps in adults with Cystic Fibrosis

Rhinosinusitis and nasal polyps in adults with Cystic Fibrosis - Sinonasal pathology and CF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36309

Enrollment

100

Registered

2011-03-22

Start date

2011-04-04

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis: mucoviscidosis rhinosinusitis: paranasal sinus infection sinusitis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnose of Cystic Fibrosis 2. Age * 18 years

Exclusion criteria

Exclusion criteria: 1. Gross immunodeficiency (congenital of acquired) 2. Congenital mucociliary problems other than CF (e.g. Primairy ciliary dyskinesia) 3. ASA syndrome (Samter*s triad; nasal polyps, asthma, and aspirin sensitivity) 4. Cocaine abuse 5. Intranasal neoplasia 6. Systemic vasculitis and granulomatous diseases (e.g. M.Wegener, sarcoidosis, Churg-Strauss syndrome) 7. Pregnancy

Design outcomes

Primary

Measure	Time frame
Prevalence of rhinosinusitis and/or nasal polyps.	—

Secondary

Measure	Time frame
Disease specific quality of life, outcome of ENT examination, nasal cultures, sputum culture, computed tomography of sinuses and nasal airway resistance.	—

Countries

Netherlands

Outcome results